3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
2
Breast Neoplasms
2
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Overweight
1
Obesity
1
Motor Activity
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Infertility
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Cognitive Dysfunction
1
Interventions
pembrolizumab
4
atezolizumab
3
Cetuximab
3
olaparib
2
Trastuzumab
2
Docetaxel
2
zimberelimab
1
tocilizumab
1
spartalizumab
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
fludarabine
1
entrectinib
1
encorafenib
1
cemiplimab
1
binimetinib
1
anlotinib
1
amivantamab
1
alectinib
1
adagrasib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Tablets
×
90 days
×
Clear all
No trials found.